Radiation and Immunotherapy Combination Shows Promise for HNSCC Treatment
A combination of radiation therapy and immunotherapy may lead to encouraging survival outcomes and acceptable toxicity for patients with locally advanced head and.
Industry News
Industry News
Enrollment Continues in Study of Oral Mucositis Medication
Soligenix is actively enrolling patients in a Phase 3 multinational, double-blind, placebo-controlled clinical trial of SGX942, or dusquetide, for the treatment of oral mucositis.
Industry News
“Magic Mouthwash” Effectively Reduces Oral Mucositis Pain
An oral rinse called “magic mouthwash” by its developers including diphenhydramine, lidocaine, and antacids significantly reduced pain from oral mucositis in patients receiving.
Industry News
Topical Anesthetic Improves Oral Mucositis Pain Treatment
Researchers at the University of Connecticut are collaborating with drug design firm Cellix Bio to develop a long-acting topical anesthetic that may replace.
